Proton Pump Inhibitors are Associated with Less Severe Periodontal Disease: Considerations for IBD Patients

被引:0
|
作者
Renata, Froes [1 ]
Andre, Moreira [1 ]
Jose, Carneiro Antonio [2 ]
Jessica, Moreira [2 ]
Ronir, Luiz [2 ]
Adriana, Moreira [3 ]
Camila, Monnerat [3 ]
de Souza, Heitor [2 ]
Ana, Pugas de Carvalho [1 ]
机构
[1] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[3] Minist Econ, Superintendencia Reg Subsecretaria Pericia Med Fe, Rio De Janeiro, Brazil
来源
关键词
D O I
10.14309/01.ajg.0000723000.65593.32
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P051
引用
收藏
页码:S13 / S13
页数:1
相关论文
共 50 条
  • [21] Clostridium difficile infection is associated with proton pump inhibitors in patients with cirrhosis
    Bajaj, Jasmohan S.
    Zadvornova, Yelena
    Hafeezullah, Muhammad
    Saeian, Kia
    HEPATOLOGY, 2007, 46 (04) : 580A - 581A
  • [22] Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children
    Chang, Tu-Hsuan
    Hsu, Wei-Yun
    Yang, Tzu-, I
    Lu, Chun-Yi
    Hsueh, Po-Ren
    Chen, Jong-Min
    Lee, Ping-Ing
    Huang, Li-Min
    Chang, Luan-Yin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (04) : 578 - 584
  • [23] Proton pump inhibitors in pediatric patients
    Fan, Ellen
    Gavura, Scott
    Ruddock, Brent
    CANADIAN PHARMACISTS JOURNAL, 2006, 139 (05) : 53 - 55
  • [24] Transplantation and proton pump inhibitors:: Risk factors for C. difficile associated disease in hospitalized patients
    Kovacs, Thomas O.
    Altman, Robyn L.
    GASTROENTEROLOGY, 2008, 134 (04) : A671 - A671
  • [25] Proton Pump Inhibitors in Patients With End-Stage Liver Disease
    Al-Khafaji, Ali
    Garavaglia, Jeffrey M.
    CRITICAL CARE MEDICINE, 2013, 41 (11) : E396 - E397
  • [26] Influence of proton pump inhibitors on microbiota in chronic liver disease patients
    Kenta Yamamoto
    Masatoshi Ishigami
    Takashi Honda
    Tomoaki Takeyama
    Takanori Ito
    Yoji Ishizu
    Teiji Kuzuya
    Kazuhiko Hayashi
    Hidemi Goto
    Yoshiki Hirooka
    Hepatology International, 2019, 13 : 234 - 244
  • [27] Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease
    Lin, R. Jun
    Sridharan, Shaum
    Smith, Libby J.
    Young, VyVy N.
    Rosen, Clark A.
    LARYNGOSCOPE, 2018, 128 (01): : 133 - 137
  • [28] Adverse events in patients with cardiovascular disease taking proton pump inhibitors
    Lanas-Gimeno, Aitor
    Lanas, Angel
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1381 - 1391
  • [29] Influence of proton pump inhibitors on microbiota in chronic liver disease patients
    Yamamoto, Kenta
    Ishigami, Masatoshi
    Honda, Takashi
    Takeyama, Tomoaki
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Goto, Hidemi
    Hirooka, Yoshiki
    HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 234 - 244
  • [30] Cardiovascular events associated with proton pump inhibitors
    Jawaid, Hafsa
    Hussain, Afshan
    Imtiaz, Fauzia
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (09) : 1466 - 1466